Insomnia May Raise Risk of Heart Attack, Stroke
SUNDAY, Nov. 4 (HealthDay News) -- People with insomnia may have
double the chances of a heart attack or stroke as opposed to those
who sleep well, a study by Taiwanese researchers suggests.
Device Offers Hope for Battery-Free Pacemakers
SUNDAY, Nov. 4 (HealthDay News) -- Implantable pacemakers have
been around for more than 50 years, but they've always had one
drawback: batteries that need to be replaced. Now, there are early
signs that a device that gains power from the patient's own
heartbeat might change all that.
Gene-Tweaked Tomatoes, Probiotics Aim to Lower Your Cholesterol
MONDAY, Nov. 5 (HealthDay News) -- People who took a probiotic
supplement containing a beneficial bacteria saw their cholesterol
levels improve, and a freeze-dried concoction made from a
genetically engineered tomato had a similar effect on mice, two new
Daily Aspirin May Help Those at Risk for Recurrent Blood Clots
MONDAY, Nov. 5 (HealthDay News) -- About a quarter of people who
experience the dangerous blood clots in the legs or lungs known as
venous thromboembolisms (VTEs) develop them for no discernable
reason, and most will receive a powerful anti-clotting drug such as
warfarin in the months after the clot forms.
Bypass Beats Stents for Diabetic Heart Patients: Study
MONDAY, Nov. 5 (HealthDay News) -- For a subset of heart
patients who are both diabetic and have more than one clogged
artery, bypass surgery appears to outperform the use of
artery-widening stents, a major new trial finds.
Xarelto's Approval Expanded
MONDAY, Nov. 5 (HealthDay News) -- Approval of the anti-clotting
drug Xarelto (rivaroxaban) has been expanded by the U.S. Food and
Drug Administration to include treating deep vein thrombosis (DVT)
or pulmonary embolism.